Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jacob Schroder

Surgery Durham, NC Medical Doctor

NPI 1699948455 CMS profile 31111

40 Duke Medicine Cir, Durham, NC 27710

Open in the dashboard

General payments

$47,289

92 records reported · program years 2019–2025

Research payments

$11,619

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,526,302 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jacob Schroder of Durham, NC is reported in the CMS Open Payments database as having received $47,289 across 92 general payments and $11,619 in research payments paid to them. Separately, studies naming them as principal investigator received $2,526,302 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,269 15
2024 General $2,805 4
2023 General $5,184 14
2022 General $1,467 10
2021 General $12,033 14
2021 Research $2,515 5
2020 General $4,576 7
2019 General $16,956 28
2019 Research $9,104 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacob Schroder
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Jacob Schroder were reported at $4,269. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Jacob Schroder Surgery median Middle half National median
2019 $16,956 $253 $82–$1,521 $163
2020 $4,576 $131 $40–$706 $114
2021 $12,033 $168 $50–$904 $132
2022 $1,467 $224 $76–$1,218 $149
2023 $5,184 $253 $82–$1,255 $160
2024 $2,805 $279 $90–$1,381 $164
2025 $4,269 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $31,749 57 payments
  2. Abiomed $6,237 17 payments
  3. CSL Behring $5,758 7 payments
  4. TransMedics, Inc. $2,427 3 payments
  5. XVIVO Perfusion Inc. $525 3 payments
  6. Medtronic, Inc. $493 2 payments
  7. Medtronic Vascular, Inc. $80 2 payments
  8. AbbVie, Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,035 25 payments
  2. Honoraria $10,020 4 payments
  3. Travel and Lodging $9,151 28 payments
  4. Food and Beverage $3,083 35 payments
Products named General payments · program years 2019–2025
  1. HeartMate 3 Left Ventricular Dev $11,204 19 payments
  2. HeartMate 3 Left Ventricular Assist Device $7,083 11 payments
  3. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $5,518 17 payments
  4. Impella $5,481 8 payments
  5. CardioMEMS HF System $4,406 5 payments
  6. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Structural Heart $3,335 3 payments
  7. ORGAN CARE SYSTEM $2,427 3 payments
  8. XVIVO Perfusion System (XPS) Transplantation $281 1 payment
  9. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Neuromodulation $197 1 payment
  10. XVIVO Perfusion System (XPS) Transplant $140 1 payment
  11. Other $99 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TransMedics, Inc. $9,104 5 payments
  2. Carmat $2,515 5 payments

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$160,104

Medicare's payments for the services billed

Medicare patients

76

Average age 66

Services billed

265

30 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Atrial fibrillation 66%
Chronic kidney disease 57%
Diabetes 43%
COPD 37%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record